Source:http://linkedlifedata.com/resource/pubmed/id/11224843
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-3-6
|
pubmed:abstractText |
Chronic mucocutaneous candidiasis should be viewed as a spectrum of disorders in which the patients have persistent and/or recurrent candidiasis of the skin, nails and mucous membranes. Some of the conditions have genetic predispositions. A common immunologic abnormality is failure of the patient's T lymphocytes to produce cytokines that are essential for expression of cell-mediated immunity to Candida. Antifungal drugs are effective in clearing the infections, and treatments that restore cellular immunity have produced long term remissions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0891-3668
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
197-206
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:11224843-Antifungal Agents,
pubmed-meshheading:11224843-Candidiasis, Chronic Mucocutaneous,
pubmed-meshheading:11224843-Humans,
pubmed-meshheading:11224843-Immunity, Cellular,
pubmed-meshheading:11224843-Immunocompetence,
pubmed-meshheading:11224843-Immunologic Deficiency Syndromes
|
pubmed:year |
2001
|
pubmed:articleTitle |
Chronic mucocutaneous candidiasis.
|
pubmed:affiliation |
Department of Medicine, University of Colorado Health Sciences Center, Denver 80206-1210, USA. ckirkpatrick@eri.uchsc.edu
|
pubmed:publicationType |
Journal Article,
Review
|